Marc Cucurull

419 total citations
17 papers, 110 citations indexed

About

Marc Cucurull is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Cucurull has authored 17 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Cucurull's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (4 papers) and Peptidase Inhibition and Analysis (4 papers). Marc Cucurull is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (4 papers) and Peptidase Inhibition and Analysis (4 papers). Marc Cucurull collaborates with scholars based in Spain and Mexico. Marc Cucurull's co-authors include Maria Saigí, Enric Carcereny, Teresa Morán, Marta Doménech, Ainhoa Hernández, Montse Sánchez‐Céspedes, Anna Estival, Andrea Plaja, Cinta Hierro and Isabel Salinas and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Marc Cucurull

17 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Cucurull Spain 6 79 37 31 17 12 17 110
Christiane Kuempers Germany 6 43 0.5× 46 1.2× 40 1.3× 17 1.0× 21 1.8× 14 113
Martina Hinterleitner Germany 6 67 0.8× 14 0.4× 36 1.2× 36 2.1× 20 1.7× 17 110
Hongqian Wu United States 4 93 1.2× 28 0.8× 22 0.7× 12 0.7× 7 0.6× 6 121
L. Zhang China 7 77 1.0× 54 1.5× 31 1.0× 16 0.9× 7 0.6× 17 141
Jasmine C. Huynh United States 7 50 0.6× 24 0.6× 18 0.6× 11 0.6× 10 0.8× 14 100
Alice Baggi Italy 6 66 0.8× 64 1.7× 20 0.6× 23 1.4× 11 0.9× 13 109
Lotus Yung United States 7 89 1.1× 38 1.0× 45 1.5× 14 0.8× 21 1.8× 12 133
Eleftheria Chorti Germany 6 101 1.3× 42 1.1× 45 1.5× 11 0.6× 6 0.5× 8 133
Juliana Machado‐Rugolo Brazil 8 64 0.8× 45 1.2× 35 1.1× 16 0.9× 20 1.7× 29 123

Countries citing papers authored by Marc Cucurull

Since Specialization
Citations

This map shows the geographic impact of Marc Cucurull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Cucurull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Cucurull more than expected).

Fields of papers citing papers by Marc Cucurull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Cucurull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Cucurull. The network helps show where Marc Cucurull may publish in the future.

Co-authorship network of co-authors of Marc Cucurull

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Cucurull. A scholar is included among the top collaborators of Marc Cucurull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Cucurull. Marc Cucurull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Saigí, Maria, José Luís Mate, Enric Carcereny, et al.. (2024). HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer. Lung Cancer. 189. 107502–107502. 2 indexed citations
2.
Carcereny, Enric, Maria Saigí, Anna Esteve, et al.. (2023). P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy. Journal of Thoracic Oncology. 18(11). S235–S235. 1 indexed citations
3.
Plaja, Andrea, María Ochoa-de-Olza, Marc Cucurull, et al.. (2023). Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery. International Journal of Molecular Sciences. 24(14). 11420–11420. 3 indexed citations
4.
Cucurull, Marc, Carolina Sanz, Enric Carcereny, et al.. (2023). Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C. Frontiers in Oncology. 13. 1239000–1239000. 2 indexed citations
5.
Cucurull, Marc, et al.. (2023). Oral ketamine for neuropathic cancer pain. BMJ Supportive & Palliative Care. 13(e3). e1–e3. 3 indexed citations
6.
Hernández, Ainhoa, Eudald Felip, Marc Cucurull, et al.. (2022). Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study. Cancers. 15(1). 137–137. 4 indexed citations
7.
Cucurull, Marc, Montse Sánchez‐Céspedes, Cinta Hierro, et al.. (2022). Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies. Frontiers in Oncology. 11. 793121–793121. 21 indexed citations
8.
Saigí, Maria, Enric Carcereny, Teresa Morán, et al.. (2022). Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer. Cancer Treatment Reviews. 109. 102430–102430. 6 indexed citations
9.
Quirant‐Sánchez, Bibiana, Eudald Felip, Maria Saigí, et al.. (2022). OA06.04 Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort. Journal of Thoracic Oncology. 17(9). S18–S18. 1 indexed citations
10.
Felip, Eudald, Edwards Pradenas, Margarita Romeo, et al.. (2022). Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV ‐2 mRNA ‐1237 vaccine in patients with solid tumors. Molecular Oncology. 17(4). 686–694. 3 indexed citations
11.
Plaja, Andrea, Teresa Morán, Enric Carcereny, et al.. (2021). 1658P Clinical characteristics of long-term survivors (LTS) in small cell lung cancer (SCLC) patients (p) with extended disease (ED). Annals of Oncology. 32. S1168–S1168. 2 indexed citations
12.
13.
Doménech, Marta, Ana M Muñoz‐Mármol, José Luís Mate, et al.. (2021). Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver. Oncotarget. 12(18). 1802–1810. 12 indexed citations
14.
Plaja, Andrea, Teresa Morán, Enric Carcereny, et al.. (2021). Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?. International Journal of Molecular Sciences. 22(24). 13508–13508. 13 indexed citations
15.
Cucurull, Marc, et al.. (2020). Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution. Translational Lung Cancer Research. 9(1). 103–110. 14 indexed citations
16.
Quiroga, Vanesa, Beatriz Cirauqui, Margarita Romeo, et al.. (2019). Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients. Scientific Reports. 9(1). 12760–12760. 19 indexed citations
17.
Cucurull, Marc, et al.. (2019). Prognostic value of monocyte to lymphocyte ratio (MLR) in epithelial ovarian cancer (EOC).. Journal of Clinical Oncology. 37(15_suppl). e17066–e17066. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christiane Kuempers Breakdown of academic impact, for papers by Martina Hinterleitner Breakdown of academic impact, for papers by Hongqian Wu Breakdown of academic impact, for papers by L. Zhang Breakdown of academic impact, for papers by Jasmine C. Huynh Breakdown of academic impact, for papers by Alice Baggi Breakdown of academic impact, for papers by Lotus Yung Breakdown of academic impact, for papers by Eleftheria Chorti Breakdown of academic impact, for papers by Juliana Machado‐Rugolo
Rankless by CCL
2026